Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
07/28/2010 | CN1872081B Application of kudzuvine root flavone in preparing medicine for treating chronic insufficiency of blood supply for brain |
07/28/2010 | CN1762354B Stable pharmaceutical composition containing calcium blocker |
07/28/2010 | CN1730018B Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparing process and application thereof |
07/28/2010 | CN1548434B Benzothiophene compounds and their preparation and medicine use |
07/28/2010 | CN101790516A Novel substituted piperidones as hsp inducers |
07/28/2010 | CN101787073A Methods and compositions for the treatment of gastrointestinal disorders |
07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
07/28/2010 | CN101787061A Application of Quzhazhigan in preparation of preparations for preventing and treating cardiac-cerebral ischemia diseases, and preparation method thereof |
07/28/2010 | CN101787016A Pyridine carboxamides as 11-beta-hsd1 inhibitors |
07/28/2010 | CN101787000A M-stage kinesin inhibitor |
07/28/2010 | CN101786992A 2-hydroxymethyl-3,5,6-trimethylpyrazine derivatives, preparation methods and application thereof |
07/28/2010 | CN101785858A Medicine combination containing isosorbide mononitrate for treating high blood pressure |
07/28/2010 | CN101785849A Traditional Chinese medicine for treating chronic rheumatic diseases |
07/28/2010 | CN101785831A Preparation method of rice bran dietary fiber |
07/28/2010 | CN101785803A Composition for suppressing cyclooxygenase and/or 5-lipoxygenase |
07/28/2010 | CN101785800A Traditional Chinese medicine combination for hepatopathy treatment |
07/28/2010 | CN101785789A Method for preparing animal gall powder |
07/28/2010 | CN101785787A Musk heartache plaster |
07/28/2010 | CN101785782A Long-circulating ligustrazine composite injection and preparation method thereof |
07/28/2010 | CN101785781A Medicine combination of levoamlodipine or medicinal salt of levoamlodipine and auricularia auricula polysaccharide, and application thereof |
07/28/2010 | CN101785772A Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
07/28/2010 | CN101785769A Solid pharmaceutical formulations comprising telmisartan |
07/28/2010 | CN101785765A Disposable hirudin stasis-eliminating hot compressing patch and applications thereof |
07/28/2010 | CN101785581A Smoking-cessation and health-care cigarette holders and using method thereof |
07/28/2010 | CN101385600B Chinese herbal medicine health-care silk quilt |
07/28/2010 | CN101288709B Orally-taken Chinese medicine for treating hemorrhoid |
07/28/2010 | CN101249108B Royal jelly acidic composition, preparation and uses thereof |
07/28/2010 | CN101224262B Chinese traditional medicine compounds for treating asthenia of qi and blood type vasculitis and preparing method thereof |
07/28/2010 | CN101152234B Application of cortex eucommiae lignans and its extract in against cardiovascular reconstruction |
07/28/2010 | CN101138578B Application of eucommia lignans and extract thereof in the preventing and controlling of diabetes complication |
07/28/2010 | CN101095724B Technics for extracting lotus leaf flavone |
07/28/2010 | CN101015584B Traditional Chinese medicine Ningxintong preparation for treating unstable angina in the coronary heart disease and preparation method thereof |
07/28/2010 | CN101012201B Ligustrazine derivative, preparation method and medical use thereof |
07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
07/27/2010 | US7763662 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol |
07/27/2010 | US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
07/27/2010 | US7763621 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
07/27/2010 | US7763620 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
07/27/2010 | US7763605 [1,4]benzodiazepines as vasopressin V2 receptor antagonists |
07/27/2010 | US7763600 Nitric ester derivatives of hormones such as progesterone, used for preventing premature labor, increasing cervical dilatation, in hormone replacement therapy, as hypeortensive agents and for treating dysmenorrhea |
07/27/2010 | US7763597 Salts |
07/27/2010 | US7763464 Generating cardiomyocytes from primate pluripotent stem cells via incubation in tissues which demonstrate spontaneous contraction, culture, separate and recover fractions which express cardiac marker proteins |
07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
07/27/2010 | US7763284 Method for treating or preventing symptoms associated with menopause |
07/27/2010 | US7763278 As cholesterol lowering agents and for treatment of cardiovascular disorders |
07/27/2010 | US7763255 Therapeutic uses of Dunaliella powder |
07/27/2010 | US7763248 Humanized collagen antibodies and related methods |
07/27/2010 | CA2629339C Pyrazolo[4,3-d]pyrimidin-5-yl) derivative used as pde5 inhibitors |
07/27/2010 | CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors |
07/27/2010 | CA2490826C Stable hydralazine pharmaceutical compositions |
07/27/2010 | CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
07/27/2010 | CA2461060C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
07/27/2010 | CA2448456C Solid pharmaceutical formulations comprising modafinil |
07/27/2010 | CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives |
07/27/2010 | CA2444266C Use of bile acid or bile salt fatty acid conjugates |
07/27/2010 | CA2437587C Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotic agents |
07/27/2010 | CA2436659C Cannabinoid receptor ligands |
07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
07/22/2010 | WO2010083207A2 Protein kinase c inhibitors and uses thereof |
07/22/2010 | WO2010082858A2 New method for obtaining 5-amino-2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine |
07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
07/22/2010 | WO2010082531A1 Active blood coagulation factor inhibitor |
07/22/2010 | WO2010081683A1 Novel eicosanoid derivatives |
07/22/2010 | WO2010081485A1 Ointment for the topical treatment of haemorrhoids |
07/22/2010 | WO2010081342A1 Methods for the preparation of ivabradine sulfate and form i crystal thereof |
07/22/2010 | WO2010081286A1 Timing controlled – release porous tablet of diltiazem hydrochloride and the preparation method thereof |
07/22/2010 | WO2010059975A3 Method of treatment of atherosclerosis by induction of immunological tolerance to collagen v |
07/22/2010 | WO2010039697A3 Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy |
07/22/2010 | WO2010037059A3 Heteroaryl antagonists of prostaglandin d2 receptors |
07/22/2010 | WO2010020904A3 Cardioplegic preparation |
07/22/2010 | WO2010015586A3 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
07/22/2010 | WO2010012438A3 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
07/22/2010 | WO2009140659A3 Treating dyspnea associated with acute heart failure with relaxin |
07/22/2010 | WO2009080198A8 Fused cynopryridines and the use thereof |
07/22/2010 | US20100184868 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products. |
07/22/2010 | US20100184864 Composite Material and Method for Production Thereof |
07/22/2010 | US20100184862 Prostacyclin derivatives |
07/22/2010 | US20100184856 Novel Compounds and Uses Thereof for Treating Inflammation and Modulating Immune Responses |
07/22/2010 | US20100184829 Rnai modulation of scap and therapeutic uses thereof |
07/22/2010 | US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
07/22/2010 | US20100184821 Compositions and Methods for Modulating Angiogenesis |
07/22/2010 | US20100184815 Agonists of peroxisome proliferator activated receptor-alpha |
07/22/2010 | US20100184814 Ester Derivatives of Losartan, Methods for Their Preparation, and Uses Thereof |
07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
07/22/2010 | US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
07/22/2010 | US20100184799 Oxadiazole beta carboline derivatives as antidiabetic compounds |
07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
07/22/2010 | US20100184789 Inhibitors of protein kinases |
07/22/2010 | US20100184788 Heterocyclic derivatives |
07/22/2010 | US20100184786 Polar Quinazolines |
07/22/2010 | US20100184784 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
07/22/2010 | US20100184783 Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
07/22/2010 | US20100184781 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
07/22/2010 | US20100184780 Inhibitors of protein kinases |
07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
07/22/2010 | US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
07/22/2010 | US20100184760 Benzoxazole kinase inhibitors and methods of use |
07/22/2010 | US20100184759 Pyrano-pyrazole-amines |
07/22/2010 | US20100184758 Beta carboline derivatives as antidiabetic compounds |